International Clinical Trial: Study on the Mechanism by Which Abnormal Pbx1 Expression Affects the Homeostasis of CD19?CD27?IgD? B Cells and Aggravates the Progression of Systemic Lupus Erythematosus

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134900) titled 'Study on the Mechanism by Which Abnormal Pbx1 Expression Affects the Homeostasis of CD19?CD27?IgD? B Cells and Aggravates the Progression of Systemic Lupus Erythematosus' on Oct. 22.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology

Condition: Systemic lupus erythematosus

Intervention: Control group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-28

Target Sample Size: Control group:50;Case group:100;

Countries of Rec...